PTK2 and osteosarcoma: In this study, our investigation into whether CCL4 affects osteosarcoma cell migration found that CCL4 promotes integrin αvβ3 expression by downregulating miR-3927-3p through the CCR5 and FAK/AKT/HIF-1α signaling pathway.